Pharmaceutical Advertising and Public Perceptions in Saudi Arabia.

IF 2 Q3 PHARMACOLOGY & PHARMACY
Pharmacy Pub Date : 2024-10-23 DOI:10.3390/pharmacy12060159
Mohammed A Alnuhait, Hana A Althobaiti, Meshari H Alharbi, Raef A Alahmadi, Yasser E Althubaiti, Abdulrahman A Alsaedi, Abdullah S Alshammari, Mahmoud E Elrggal, Mohammed A Alrashed, Mohamed A Albekery, Abdullah A Alhifany, Abdulmalik S Alotaibi
{"title":"Pharmaceutical Advertising and Public Perceptions in Saudi Arabia.","authors":"Mohammed A Alnuhait, Hana A Althobaiti, Meshari H Alharbi, Raef A Alahmadi, Yasser E Althubaiti, Abdulrahman A Alsaedi, Abdullah S Alshammari, Mahmoud E Elrggal, Mohammed A Alrashed, Mohamed A Albekery, Abdullah A Alhifany, Abdulmalik S Alotaibi","doi":"10.3390/pharmacy12060159","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>As the pharmaceutical advertising landscape evolves with digital advancements, this study examines public awareness and perceptions of medication advertisements in Saudi Arabia. It focuses on the effects of regulatory frameworks and evaluates how they influence public understanding and attitudes toward these advertisements.</p><p><strong>Method: </strong>A cross-sectional study was conducted using an electronic survey in Saudi Arabia in December 2023. The survey was distributed on social media platforms and reached a diverse sample of 440 participants. It covered public perception and attitudes toward drug advertisements, knowledge of regulatory laws, and preferences regarding advertising mediums.</p><p><strong>Results: </strong>Out of the 440 participants in the study, who were primarily employees with bachelor's degrees, there was a clear awareness of drug advertisements. The average age of the group was 33 years, and a significant portion (71.1%) held a bachelor's degree, with 51.1% being employed. The findings revealed that 25.5% of participants frequently noticed drug ads, while 22.7% saw them very often. Although many found the ads informative, there were significant concerns about unrealistic expectations and the risk of overmedication; 89.8% believed the ads set unrealistic expectations about the effectiveness of medications. Additionally, 60.7% thought that celebrity endorsements might mislead the audience, and 91.1% felt that ads should provide more detailed information about potential risks and side effects. Regarding preferred advertising platforms, mobile apps and websites were favored (47%), followed closely by social media (46.4%). A striking 93.2% of participants believed that drug ads on social media should be subject to stricter regulations, and 96.4% wanted more proactive monitoring of online advertising. Many also reported using other sources, such as medical review sites, to verify medication information.</p><p><strong>Conclusions: </strong>Pharmaceutical advertising in Saudi Arabia must balance ethical transparency with educational value. The influence of digital platforms underscores the necessity for stricter regulation and accurate information dissemination. A collaborative approach is essential to align advertising practices with public health interests and regulatory standards.</p>","PeriodicalId":30544,"journal":{"name":"Pharmacy","volume":"12 6","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503259/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pharmacy12060159","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: As the pharmaceutical advertising landscape evolves with digital advancements, this study examines public awareness and perceptions of medication advertisements in Saudi Arabia. It focuses on the effects of regulatory frameworks and evaluates how they influence public understanding and attitudes toward these advertisements.

Method: A cross-sectional study was conducted using an electronic survey in Saudi Arabia in December 2023. The survey was distributed on social media platforms and reached a diverse sample of 440 participants. It covered public perception and attitudes toward drug advertisements, knowledge of regulatory laws, and preferences regarding advertising mediums.

Results: Out of the 440 participants in the study, who were primarily employees with bachelor's degrees, there was a clear awareness of drug advertisements. The average age of the group was 33 years, and a significant portion (71.1%) held a bachelor's degree, with 51.1% being employed. The findings revealed that 25.5% of participants frequently noticed drug ads, while 22.7% saw them very often. Although many found the ads informative, there were significant concerns about unrealistic expectations and the risk of overmedication; 89.8% believed the ads set unrealistic expectations about the effectiveness of medications. Additionally, 60.7% thought that celebrity endorsements might mislead the audience, and 91.1% felt that ads should provide more detailed information about potential risks and side effects. Regarding preferred advertising platforms, mobile apps and websites were favored (47%), followed closely by social media (46.4%). A striking 93.2% of participants believed that drug ads on social media should be subject to stricter regulations, and 96.4% wanted more proactive monitoring of online advertising. Many also reported using other sources, such as medical review sites, to verify medication information.

Conclusions: Pharmaceutical advertising in Saudi Arabia must balance ethical transparency with educational value. The influence of digital platforms underscores the necessity for stricter regulation and accurate information dissemination. A collaborative approach is essential to align advertising practices with public health interests and regulatory standards.

沙特阿拉伯的药品广告和公众认知。
导言:随着数字技术的发展,药品广告的格局也在不断变化,本研究探讨了沙特阿拉伯公众对药品广告的认识和看法。研究重点是监管框架的效果,并评估它们如何影响公众对这些广告的理解和态度:方法:2023 年 12 月在沙特阿拉伯进行了一项横断面研究,采用电子调查的方式。该调查在社交媒体平台上发布,共有 440 名参与者参与。调查内容包括公众对药品广告的看法和态度、对监管法律的了解以及对广告媒体的偏好:参与研究的 440 名参与者主要是拥有学士学位的雇员,他们对药品广告有明显的认知。他们的平均年龄为 33 岁,很大一部分(71.1%)拥有学士学位,其中 51.1%为在职人员。调查结果显示,25.5% 的参与者经常注意到药品广告,22.7% 的参与者非常经常注意到药品广告。尽管许多人认为广告信息量很大,但他们对不切实际的期望和过度用药的风险表示了极大的担忧;89.8% 的人认为广告对药物的疗效设定了不切实际的期望。此外,60.7% 的人认为名人代言可能会误导受众,91.1% 的人认为广告应提供有关潜在风险和副作用的更详细信息。关于首选的广告平台,移动应用程序和网站受到青睐(47%),社交媒体紧随其后(46.4%)。93.2%的参与者认为社交媒体上的药品广告应受到更严格的监管,96.4%的参与者希望对网络广告进行更积极的监控。许多人还表示会使用其他渠道(如医学评论网站)来核实药品信息:沙特阿拉伯的药品广告必须兼顾道德透明度和教育价值。数字平台的影响凸显了更严格监管和准确信息传播的必要性。要使广告行为符合公众健康利益和监管标准,必须采取合作方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacy
Pharmacy PHARMACOLOGY & PHARMACY-
自引率
9.10%
发文量
141
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信